header-image

Theses 2016

Within Sanquin around 80 PhD students are working on a thesis. In most cases Sanquin Researchers that hold a professorhip at one of the Dutch universities act as supervisor/promotor.


Most PhD students follow courses at those universities, as part of their research training. Sanquin researchers also contribute to these courses. Each year, around 15 PhD theses are defended.

 

PhD student Date Title
Anna Daniel 5 February 2016 In sickness and in health”. Regulation of junctional integrity in Inflamed and healthy endothelial cells
Mark van der Garde 9 February 2016 Different strategies to improve the use of umbilical cord and cord blood for hematopoietic and other regenerative cell therapies
Maarten van de Klundert 16 February 2016 On the molecular biology of the hepatitis B virus X protein
Katka Szilagyi 26 February 2016 Role of Inflammation in Development of Atherosclerosis
Esther van Wezel 28 April 2016 'Minimal residual disease monitoring in neuroblastoma'
Anne Wevers 17 May 2016 'Blood, sweat and fears: understanding and influencing blood donor behaviour'
Welling Oei 21 June 2016 'Modelling the risk of emerging infections for blood transfusion'
Reindert Emmens 5 July 2016 ‘The inflammatory response in myocarditis and acute myocardial infarction’
Roel Gazendam 28 September 2016 'Neutrophil microbial killing mechanisms. Lessons learned from primary immunodeficiencies'
Tamara Stegmann 29 September 2016 'Immune responses to red blood cell antigens'
Elena Kostova 5 October 2016 ‘TRUE BLOOD. From storage to immune adherence clearance’
Ryanne Lieshout-Krikke 29 November 2016 ‘Residual infectious risks in blood transfusion’
Eva Rombout-Sestrienkova 8 December 2016 ‘Erythrocytapheresis, a treatment modality in hereditary hemochromatosis’
Florentine Thurik 8 December 2016 ‘Cell-free placental DNA beyond Down syndrome - Lessons learned from fetal RHD genotyping’

 

External theses

Theses from non-Sanquin researchers where Sanquin researchers act as (co)promotor

Louis Jansen. Virus-Host Interplay in Chronic Hepatitis B. Predicting Response to Immunomodulating Antiviral Therapy.

  • University of Amsterdam. 15 January 2016
  • Promotores: Prof HL Zaaijer PhD and prof UHW Beuers PhD;
  • copromotor: HW Reesink PhD and NA Kootstra PhD

Anniki de Niet. New Treatment Strategies for Chronic Hepatitis B. Viral, Genetic and Immunological Factors Predicting Treatment Outcome.

  • University of Amsterdam. 2 February 2016
  • Promotores: Prof HL Zaaijer PhD and prof UHW Beuers PhD;
  • copromotor: HW Reesink PhD and NA Kootstra PhD

Kirsten Hertoghs. In search of a master regulator of cytotoxicity: Transcriptional control of cytolytic effector function in human lymphocytes.

  • University of Amsterdam. 20 February 2016
  • Promotores: Prof RAW van Lier PhD;
  • copromotor: KPJM van Gisbergen PhD

Alice van Velzen. INSIGHT in risk factors and treatment of inhibitors in nonsevere hemophilia A.

  • University of Amsterdam. 7 juli 2016
  • Promotores: Prof CJ Fijnvandraat MD PhD and prof TW Kuijpers MD PhD;
  • copromotor: M Peters PhD

Marleen Straat. Unexpected effect of transfusion in the critically ill.

  • University of Amsterdam. 8 juli 2016
  • Promotores: Prof MB Vroom MD PhD;
  • copromotor: prof NP Juffermans MD PhD and R van Bruggen PhD

Kazem Nasserinejad. Modeling Longitudinal Data of Blood Donors.

  • Erasmus University Rotterdam. 9 September 2016
  • Promotores: Prof EMEH Lesaffre and prof WLAM. de Kort;
  • copromotor: JM van van Rosmalen PhD

Michiel van Aalderen. The individuality of (virus-specific) CD8+ T cells.

  • University of Amsterdam. 28 oktober 2016
  • Promotores: Prof RJM ten Berge MD PhD and prof RAW van Lier MD PhD

Katja MJ Heitink-Polle. Pediatric Immune Thrombocytopenia: To treat or not to treat.

  • Utrecht University. 17 November 2016
  • Promotores: Prof EES Nieuwenhuis PhD and prof M de Haas PhD;
  • copromotor: MCA Bruin PhD